https://www.inflation.us/content/trio-tech-international-aehr-test-systems-poet-technologies

(excerpt)

Instead of investing into a real AI company like Trio-Tech International (TRT) that is highly profitable and currently has an enterprise value at $7.41 per share of only $15.83 million or 0.374X revenue of $42.31 million, investors are being suckered into buying a boiler room company POET Technologies Inc. (POET) that has total revenue of $116,000 yet is trading at a market cap of $286.32 million. POET has nothing to do with AI and has developed nothing innovative whatsoever!

We live in a world where people are incapable of doing any due diligence. They buy stocks based on tips they receive from incompetent losers on Reddit and YouTube. Anybody who does the slightest bit of research realizes that TRT is a much better company than AEHR and especially POET.